The page is the record's research on the issuer — no analyst, no rating, no view.

# Ascelia Pharma AB (Nasdaq Stockholm: SE0010573113) — research page

As of 2026-11-06 · se-cm-kg · record version 1

## Identity and listing

Ascelia Pharma AB is listed on Nasdaq Stockholm under the ticker SE0010573113, with ISIN SE0010573113 and LEI 5493002YR9VCJJPWYN08. Its security type, segment, sector and jurisdiction are not on the record. Its listing status is listed, not halted.

## The disclosure read

The record holds 25 filings across 25 filing days in the twelve months to 2026-11-06. The median gap between filing days is 12.0 days. The latest filing is dated 2026-11-05 and is of type Interim report (Q1 and Q3), 1 day before the record date. The Nasdaq Stockholm median is 9.5 days for cadence, 30.0 filings and 7.0 days of latency across 398 issuers. The sector median is not on the record.

## Auditor

The auditor of record and its location are not on the record. Auditor changes are not on the record, because this register has no lifecycle type map yet.

## Events and halts

Listing, delisting, name change, domicile change and segment move are not on the record, because this register has no lifecycle type map yet. The record shows the issuer as listed, not halted.

## Orderability

The outcome is not determinable under acm-68000/se/mifid-ii-product-governance/r1, because the chapter's orderability section carries no client categories. The chapter is as of 2026-11-04.

## Coverage

Three research houses are named on the issuer's investor-relations page: DNB Carnegie, Redeye and ABG Sundal Collier.

## Open research

Four openly published research notes are on the record: DNB Carnegie on 2025-05-19, ABG Sundal Collier on 2025-04-25, DNB Carnegie on 2025-02-11, and Edison Group on 2019-05-21.

## Licensed

Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.

## As-of depth

The market's vintage is not sealed. No years are sealed for the issuer. The earliest sealed date of the market is not on the record, and the live record began on no date.

## Sources

11 source pages are named on this page; every value above carries its own source page and read date in the numbers.

- https://firds.esma.europa.eu/firds/ (identity.exchange)
- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)
- https://mcp.se-cm-kg.ai/events/XSTO/SE0010573113 (the disclosure lines)
- https://api.news.eu.nasdaq.com/news/query.action?globalGroup=exchangeNotice&globalName=ExchangenewsFilter|FirstNorthInformation (the halt flag)
- https://se.eu-cm-kg.ai/book/aio.json (the orderability chapter)
- https://www.ascelia.com/equity-research/ (coverage)
- https://www.ascelia.com/wp-content/uploads/2025/05/250519-Carnegie-Access.pdf (open research)
- https://www.ascelia.com/wp-content/uploads/2025/05/Improving-cancer-contrast.pdf (open research)
- https://www.ascelia.com/wp-content/uploads/2025/02/250211-Carnegie-Access.pdf (open research)
- https://www.ascelia.com/wp-content/uploads/2019/05/190521-Equity-Research-Edison-Group.pdf (open research)
- https://mcp.se-cm-kg.ai/record/XSTO/SE0010573113 (the record)

---
Allooloo Technologies Corp. · https://getresearch.ai/se/XSTO/SE0010573113 · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp
